blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0570375

EP0570375 - NOVEL PEPTIDES WITH ANTICOAGULATORY EFFECT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.02.1996
Database last updated on 13.07.2024
Most recent event   Tooltip23.02.1996No opposition filed within time limitpublished on 10.04.1996 [1996/15]
Applicant(s)For all designated states
BASF Aktiengesellschaft
Carl-Bosch-Strasse 38
67063 Ludwigshafen / DE
[N/P]
Former [1993/47]For all designated states
BASF Aktiengesellschaft
Carl-Bosch-Strasse 38
D-67063 Ludwigshafen / DE
Inventor(s)01 / SCHMIED, Bernhard
Taunusstrasse 20
D-6710 Frankenthal / DE
02 / HOEFFKEN, Hans, Wolfgang
Dammstueckerweg 101
D-6700 Ludwigshafen / DE
03 / HORNBERGER, Wilfried
Mundenheimer Strasse 152
D-6700 Ludwigshafen / DE
04 / BERNARD, Harald
Valentin Ostertag-Strasse 2
D-6702 Bad Duerkheim / DE
[1995/16]
Former [1993/47]01 / SCHMIED, Bernhard
Taunusstrasse 20
D-6710 Frankenthal / DE
02 / HOEFFKEN, Hans, Wolfgang
Dammstueckerweg 101
D-6700 Ludwigshafen / DE
03 / HORNBERGER, Wilfried
Mundenheimer Strasse 152
D-6700 Ludwigshafen / DE
04 / BERNARD, Harald
Valentin-Ostertag-Strasse 2
D-6702 Bad Duerkheim / DE
Application number, filing date91920137.621.11.1991
[1993/47]
WO1991EP02191
Priority number, dateDE1991410364907.02.1991         Original published format: DE 4103649
[1993/47]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO9213879
Date:20.08.1992
Language:DE
[1992/22]
Type: A1 Application with search report 
No.:EP0570375
Date:24.11.1993
Language:DE
The application published by WIPO in one of the EPO official languages on 20.08.1992 takes the place of the publication of the European patent application.
[1993/47]
Type: B1 Patent specification 
No.:EP0570375
Date:19.04.1995
Language:DE
[1995/16]
Search report(s)International search report - published on:EP20.08.1992
ClassificationIPC:C07K7/06, A61K38/55
[1995/16]
CPC:
C07K14/815 (EP,US); A61P7/02 (EP); A61K38/00 (EP,US)
Former IPC [1993/47]C07K7/06, // A61K37/64
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   NL,   SE [1993/47]
TitleGerman:NEUE ANTIKOAGULATORISCH WIRKSAME PEPTIDE[1993/47]
English:NOVEL PEPTIDES WITH ANTICOAGULATORY EFFECT[1993/47]
French:NOUVEAUX PEPTIDES A ACTIVITE ANTICOAGULANTE[1993/47]
Entry into regional phase25.03.1993National basic fee paid 
25.03.1993Designation fee(s) paid 
25.03.1993Examination fee paid 
Examination procedure29.04.1992Request for preliminary examination filed
International Preliminary Examining Authority: DE
25.03.1993Examination requested  [1993/47]
09.05.1994Despatch of communication of intention to grant (Approval: No)
27.07.1994Despatch of communication of intention to grant (Approval: later approval)
04.08.1994Communication of intention to grant the patent
06.10.1994Fee for grant paid
06.10.1994Fee for publishing/printing paid
Opposition(s)20.01.1996No opposition filed within time limit [1996/15]
Fees paidRenewal fee
20.11.1993Renewal fee patent year 03
25.11.1994Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO9003391  (BIOGEN INC [US]);
 [A]EP0372670  (BIOGEN INC [US], et al);
 [A]WO9101328  (BIOGEN INC [US]);
 [AP]EP0443598  (BEHRINGWERKE AG [DE]);
 [AP]EP0443429  (MERRELL DOW PHARMA [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.